H K Müller-Hermelink1, A Greiner
1Pathologisches Institut, Universität Würzburg.
Autoantibodies are common in healthy individuals and can drive malignant transformation in B-cells. Understanding these auto-reactive receptors is key to developing new treatments for autoimmune diseases and lymphoma.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: